Zentek (CVE:ZEN) Shares Down 31.6% – Time to Sell?

Shares of Zentek Ltd. (CVE:ZENGet Free Report) were down 31.6% during trading on Friday . The company traded as low as C$0.86 and last traded at C$0.93. Approximately 1,053,227 shares traded hands during mid-day trading, an increase of 1,143% from the average daily volume of 84,742 shares. The stock had previously closed at C$1.36.

Zentek Price Performance

The stock has a 50-day simple moving average of C$0.80 and a 200 day simple moving average of C$0.94. The company has a debt-to-equity ratio of 15.41, a quick ratio of 7.59 and a current ratio of 1.00. The company has a market cap of C$100.02 million, a P/E ratio of -11.63 and a beta of 0.34.

About Zentek

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

Featured Stories

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.